ABSTRACT
Nine female patients with the rare congenital arteriovenous malformation of the pelvis were treated at New York University Medical Center in the past 8 years. The patients varied significantly in the anatomic location of the arteriovenous malformation, clinical presentation, and natural course of disease. A gynecologic perspective on the management of this condition is presented, which ranges from a conservative approach with preservation of childbearing potential to extensive pelvic surgery. The important role of modern interventional radiology technology and the multidisciplinary approach are stressed. The unpredictable course of disease after any intervention should be emphasized in planning the management of pelvic arteriovenous malformation.
Subject(s)
Arteriovenous Malformations/therapy , Pelvis/blood supply , Adult , Angiography , Arteriovenous Malformations/diagnosis , Arteriovenous Malformations/diagnostic imaging , Embolization, Therapeutic , Female , Humans , Hysterectomy , Magnetic Resonance Imaging , Middle Aged , Pelvic Exenteration , Uterine Hemorrhage/etiology , Uterine Hemorrhage/surgery , Uterine Hemorrhage/therapyABSTRACT
A uterine arteriovenous malformation was diagnosed angiographically in a 27-year-old woman presenting with recurrent menometrorrhagia. Bilateral hypogastric artery embolization with a liquid polymer, isobutyl 2-cyanoacrylate (Bucrylate), resulted in subsequent normal menses. Bucrylate offers a number of advantages over other agents previously used to embolize uterine arteriovenous malformations.
